TScan Therapeutics, Inc. (TCRX)

NASDAQ: TCRX · Real-Time Price · USD

0.9724

-0.0241 (-2.42%)

At close: Feb 11, 2026, 4:00 PM EST

0.9511

-0.0213 (-2.19%)

After-hours: Feb 11, 2026, 5:12 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
T Cell Receptor-engineered T Cell	2.82M
T Cell Receptor-engineered T Cell Growth	-86.62%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
United States	2.82M
United States Growth	-86.62%